Le marché mondial des réactifs de diagnostic des anticorps monoclonaux était évalué à 7 654,06 millions de dollars américains en 2021 ; on estime qu'il croîtra à un TCAC de 13,5 % de 2022 à 2028.
Les anticorps monoclonaux (mAb) sont des réactifs de diagnostic importants qui sont utilisés dans la recherche biomédicale ; recherche microbiologique; dans le diagnostic de l'hépatite, du SIDA, de la grippe, de l'herpès simplex, des infections à chlamydia ; et dans le traitement des infections et du cancer. Les anticorps monoclonaux dirigés contre des épitopes uniques sont hautement spécifiques, homogènes et peuvent être produits en quantités illimitées. La technologie des anticorps monoclonaux dérivés d'hybridomes ou clonés par voie bactérienne a permis la production en masse de sondes hautement spécifiques pour des sites antigéniques, que ce soit sur des hormones, des enzymes, des récepteurs ou des produits microbiens. Les principaux facteurs à l'origine de la croissance de ce marché incluent la prévalence croissante du cancer et d'autres maladies chroniques, la présence d'un solide portefeuille de médicaments à l'essai et des efforts de R&D considérables pour développer de nouvelles thérapies.
Le rapport offre des informations et une analyse approfondie du marché des réactifs de diagnostic d'anticorps monoclonaux, mettant l'accent sur divers paramètres, y compris les tendances du marché, les avancées technologiques, le marché dynamique et analyse du paysage concurrentiel des principaux acteurs du marché mondial. Il inclut également l'impact de la pandémie de COVID-19 sur le marché dans toutes les régions.
L'impact global de la pandémie de COVID-19 sur le marché des réactifs de diagnostic des anticorps monoclonaux a été positif ; par conséquent, le marché continue de gagner du terrain et devrait croître dans les années à venir. Celltrion Group a annoncé que le ministère coréen de la sécurité alimentaire et des médicaments (MFDS) a approuvé le regdanvimab (CT-P59), un anticorps monoclonal pour le traitement du COVID-19 pour une utilisation prolongée chez les patients âgés de 50 ans et plus, ou avec au moins une condition médicale sous-jacente telle que l'obésité, les maladies cardiovasculaires, les maladies pulmonaires chroniques, le diabète, maladie rénale chronique, maladie hépatique chronique et patients avec des agents immunosuppresseurs présentant des symptômes légers de COVID-19, et patients adultes présentant des symptômes modérés de COVID-19. En outre, la thérapie par anticorps monoclonaux, qui a été utilisée avec succès dans d'autres pays pour traiter les patients atteints de COVID-19 présentant des symptômes légers ou modérés, a maintenant été approuvée par le Contrôleur général des médicaments de l'Inde (DCGI) pour une utilisation en Inde.< /p>
Insights stratégiques
Insights basés sur la géographie
Par géographie, le marché mondial des réactifs de diagnostic des anticorps monoclonaux est segmenté en Amérique du Nord (États-Unis, Canada et Mexique), Europe ( France, Allemagne, Royaume-Uni, Espagne, Russie, Italie et Reste de l'Europe), Asie-Pacifique (Chine, Inde, Japon, Australie, Corée du Sud, Kazakhstan et Reste de l'APAC), Moyen-Orient & Afrique (Arabie saoudite, Émirats arabes unis, Afrique du Sud et reste du Moyen-Orient et de l'Afrique) et Afrique du Sud et amp; Amérique centrale (Brésil, Argentine et reste de l'Amérique du Sud et centrale).
Régions lucratives pour le marché des réactifs de diagnostic d'anticorps monoclonaux
Informations sur le marché
Des efforts considérables de R&D pour développer de nouvelles thérapies
Les nombreuses applications des mAb impliquent la prévention, le diagnostic et le traitement des maladies. L'application des mAbs dans le diagnostic est la plus avancée, en particulier pour les tests effectués sur les fluides corporels tels que l'urine et le sang. De plus, l'application de diagnostic mAbs comprend des techniques telles que l'ELISA, le transfert Western, le transfert immunologique, la cytométrie en flux, l'immunohistochimie, le dosage radioimmunologique et la microscopie électronique. En outre, les mAb destinés à une application diagnostique peuvent détecter des antigènes et des anticorps contre les maladies virales et fongiques du bétail et les maladies parasitaires.
En outre, les mAb sont des réactifs appréciés destinés à de nombreuses applications en raison de leur sélectivité, de leur affinité de liaison élevée et de leur immunogénicité/faible toxicité ; Les mAb sont les mieux adaptés à la recherche clinique, environnementale et élémentaire. Les applications diagnostiques des mAb comprennent également les dispositifs médicaux, les tests in vitro et l'l'imagerie médicale< /a>
De plus, l'utilité des mAbs s'est élargie pour comprendre un large éventail de maladies en contribuant au développement de nouveaux traitements d'immunothérapie. Par exemple, les thérapies anticancéreuses ont bénéficié de la recherche sur les mAb, très probablement pour le développement de RituximAb, prouvant un traitement efficace pour de nombreux cancers. En outre, de nombreux mAb sont désormais reconnus par la Food and Drug Administration (FDA) des États-Unis comme sûrs pour une utilisation dans des thérapeutiques commerciales. Les facteurs mentionnés ci-dessus devraient contribuer à la croissance du marché des réactifs de diagnostic des anticorps monoclonaux au cours de la période de prévision.
Insights basés sur des tests
Sur la base de tests, le marché mondial des réactifs de diagnostic d'anticorps monoclonaux est segmenté en méthode de chimiluminescence en sandwich à double antigène, test d'immunoabsorption enzymatique, test d'immunoblot recombinant et test de filtration dot-immunogold. En 2021, le segment des dosages immuno-enzymatiques représentait la plus grande part de marché, et il devrait enregistrer le TCAC le plus élevé de 2022 à 2028.
Marché mondial des réactifs de diagnostic des anticorps monoclonaux, par tests 2021 et 2028
Insights basés sur les applications< /span>
Sur la base des applications, le marché mondial des réactifs de diagnostic des anticorps monoclonaux est segmenté en hormones diagnostic, surveillance des tumeurs, détection de virus et autres applications. Le segment de la surveillance des tumeurs détenait la plus grande part de marché en 2021, et il devrait enregistrer le TCAC le plus élevé au cours de la période de prévision.
Les acteurs du marché mondial des réactifs de diagnostic des anticorps monoclonaux adoptent des stratégies organiques, y compris le lancement et l'expansion de produits, pour étendre leur empreinte et leur portefeuille de produits dans le monde entier et répondre à la demande croissante de produits. Quelques-uns des principaux acteurs opérant sur le marché sont BioGenex ; Bio-Rad Laboratories, Inc. ; Biocare Medical, LLC ; Celltrion Healthcare Co., Ltd. ; diagnostics créatifs ; GenWay Biotech ; Thermo Fisher Scientific Inc. ; ABclonal, Inc.; Apto-Gen ; et Abcam plc.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Monoclonal antibodies (mAb) are important diagnostic reagents that are being used in biomedical research, microbiological research in diagnosis of Hepatitis, AIDs, influenza, herpes simplex, chlamydia infections and in treatment of infections and cancer. The monoclonal antibodies being directed against single epitopes are highly specific, homogeneous and can be produced in unlimited quantities. The hybridoma-derived or bacterially cloned monoclonal antibody technology has enabled the mass production of highly specific probes for antigenic sites, whether on hormones, enzymes, receptors, or microbial products.
Rising prevalence of cancer and other chronic diseases, extensive R&D efforts to develop novel therapies, and presence of strong pipeline of drugs under trial are the major factors contributing to the growth of the monoclonal antibody diagnostic reagent industry.
The monoclonal antibody diagnostic reagent market majorly consists of the players, such as BioGenex; Bio-Rad Laboratories, Inc.; Biocare Medical, LLC; Celltrion Healthcare Co., Ltd.; Creative Diagnostics; GenWay Biotech; Thermo Fisher Scientific Inc.; ABclonal, Inc.; Apto-Gen; and Abcam plc.
The CAGR value of the monoclonal antibody diagnostic reagent market during the forecasted period of 2022-2028 is 13.5%
The monoclonal antibody diagnostic reagent market is estimated to be valued at US$ 8,642.00 million in 2022.
The monoclonal antibody diagnostic reagent market is expected to be valued at US$ 18,507.20 million in 2028.
The enzyme-linked immunosorbent assay segment held the largest share of the market in the global monoclonal antibody diagnostic reagent market contributing a market share of 37.89% in 2021.
The Asia Pacific is expected to be the fastest-growing region in the monoclonal antibody diagnostic reagent market over the forecast period due to growing investments from international players in China and India, increasing disposable income, and chronic diseases in these regions will show promising growth in the monoclonal antibody diagnostic reagent market.
The List of Companies - Monoclonal Antibody Diagnostic Reagent Market
- BioGenex
- Bio-Rad Laboratories, Inc.
- Biocare Medical, LLC
- Celltrion Healthcare Co., Ltd.
- Creative Diagnostics
- GenWay Biotech
- Thermo Fisher Scientific Inc.
- ABclonal, Inc.
- Apto-Gen
- Abcam plc.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Related Reports
Sep 2022
Colonoscopes Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Fiber Optic Colonoscopy Devices, Video Colonoscopy Devices); Application (Colorectal Cancer, Lynch Syndrome, Ulcerative Colitis, Crohn's Disease, Polyp); End User (Hospitals, Ambulatory Surgery Center, Others), and Geography
Sep 2022
Noninvasive Fat Reduction Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Technology (Cryolipolysis, Laser Lipolysis, Ultrasound, and Others), End User (Hospitals, Dermatology Clinics & Cosmetic Clinics, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Sep 2022
Medical Ultrasound Flow Meter Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Implementation Type (Clamp-On, Inline, and Others), Technology (Doppler, Transit Time, and Hybrid), Application (Heart and Lung Machines, Extracorporeal Membrane Oxygenation, Perfusion, Organ Transportation Systems, and Others), End User (Hospitals and Clinics, Ambulatory Surgical Centers, Research Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Sep 2022
Rapid Test Kits Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Rapid Antigen Testing, Rapid Antibody Testing, and Others), Product (Over-the-Counter Rapid Testing Kit and Professional Rapid Testing Kit), Technology (Lateral Flow Assay, Solid Phase, Agglutination, Immunospot Assay, and Cellular Component-Based), Application (Blood Glucose Testing, Infectious Disease Testing, Pregnancy and Fertility, Cardiometabolic Testing, and Others), End User (Hospital and Clinics, Home Care, Diagnostics Centers, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Sep 2022
Osteoarthritis Therapy Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Therapy Type [Transcutaneous Electrical Nerve Stimulation (TENS), Occupational Therapy, Physical Therapy, Platelet-Rich Plasma Therapy and Stromal Vascular Fraction, Prolotherapy, and Others], Disease Indication (Knee Osteoarthritis, Spine Osteoarthritis, Foot and Ankle Osteoarthritis, Shoulder Osteoarthritis, Hand Osteoarthritis, and Others), End User (Hospitals & Clinics, Specialty Clinics, Ambulatory Surgical Centers, Homecare, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Sep 2022
Bariatric Surgeries Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Type [Adjustable Gastric Bands (AGB), Sleeve Gastrectomy, Gastric Bypass, Biliopancreatic Diversion with Duodenal Switch (BPD-DS), and Others], End User (Hospitals and Ambulatory Surgical Centers), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Sep 2022
Post-Acute Care Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Service Type (Skilled Nursing Facilities, Inpatient Rehabilitation Facilities, Long-Term Care Hospitals, Home Health Agency, and Others), Age (Elderly, Adult, and Others), Disease Conditions (Amputations, Wound Management, Brain Injury and Spinal Cord Injury, Neurological Disorders, and Others), and Geography
Sep 2022
Lung Cancer Therapy Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Therapy Type (Noninvasive and Minimally Invasive), Indication (Non-Small Cell Lung Cancer and Small Cell Lung Cancer), End User (Hospitals, Oncology Clinics, Research Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)